Supratentorial Ependymoma — Trials

Supratentorial Ependymoma — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01462695	Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma	completed	Phase 2	30	National Cancer Institute (NCI)NIH	3	Aug 27, 2015	clinicaltrials
NCT00004078	Irinotecan in Treating Children With Refractory Solid Tumors	completed	Phase 2	181	Children's Oncology GroupNETWORK	1	Jun 14, 2013	clinicaltrials

Data updated 22 days agoSource updated Aug 27, 2015source: clinicaltrials